Bio-Rad EVP & General Counsel Courtney Enloe Reports RSU Grant and Vesting Activity
BIO-RAD LABORATORIES, INC.
Subscribe to track BIO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Bio-Rad Laboratories, Inc. (BIO) - Form 4 Filing Summary
**Insider:** Courtney C. Enloe (EVP, General Counsel & Sec)
**Filing Date:** September 9, 2026
**Period of Report:** September 4, 2026
### Summary of Transactions
- **RSU Grant (Sept 4, 2026):** Received 2,876 Restricted Stock Units (vesting over 4 years).
- **RSU Vestings (Sept 5–6, 2026):** Acquired 1,453 Class A Common shares (685 + 768) upon vesting.
- **Tax Withholdings (Sept 5–6, 2026):** 551 shares (246 + 305) withheld to cover taxes at $386.11/share (~$212,746 total value).
- **Ending Direct Holdings:** 1,651.777 shares of Class A Common Stock
**Significance:** Low (Routine equity award and tax withholding on vesting)
Comprehensive Analysis
Bio-Rad Laboratories, Inc. (BIO) Form 4 Analysis
Executive Overview
Courtney C. Enloe, Executive Vice President, General Counsel & Secretary of Bio-Rad Laboratories, Inc., reported equity compensation grant and routine vesting activity covering transactions from September 4 to September 6, 2026.
Breakdown of Activity
-
Equity Award Grant (September 4, 2026):
- Derivative Security: Restricted Stock Units (RSUs)
- Amount: 2,876 units (convertible 1:1 into Bio-Rad Class A Common Stock)
- Vesting Schedule: Vests over four years (25% on the first anniversary, remaining in quarterly installments).
-
RSU Vesting and Net Settlement (September 5–6, 2026):
- September 5, 2026: 685 RSUs vested into Class A Common Stock. 246 shares were withheld (Code F) for tax obligations at $386.11 per share ($94,983.06).
- September 6, 2026: 768 RSUs vested into Class A Common Stock. 305 shares were withheld (Code F) for tax obligations at $386.11 per share ($117,763.55).
- Total Net Shares Added: 902 Class A Common shares.
Ownership Post-Transaction
- Direct Ownership (Class A Common Stock): 1,651.777 shares
- Remaining RSUs Owned: 6,467 units across existing grants
Trading Significance
This filing represents standard executive compensation grants and non-discretionary tax withholding dispositions associated with scheduled RSU vestings. It does not reflect open-market buying or selling.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.